Navigation Links
Schering-Plough Reports Financial Results for Third Quarter of 2008
Date:10/21/2008

===== =====

Average shares

outstanding-

diluted 1,622 1,622

(1) "As Reconciled" to exclude purchase accounting adjustments, special

and acquisition-related items and other specified items.

(2) Diluted earnings per common share for the three month period ended

September 30, 2007 is calculated using a numerator of $731 million, which

is the arithmetic sum of net income available to common shareholders of

$713 million plus dividends of $18 million related to the 2004 preferred

stock which are dilutive, and a denominator of 1,622 which represents the

average diluted shares outstanding for the third quarter of 2007. The

2004 preferred stock was dilutive under accounting rules. The 2007

preferred stock was not dilutive for the three months ended September 30,

2007.

SCHERING-PLOUGH CORPORATION

Reconciliation from Reported Net Income Available to Common Shareholders

and Reported Diluted Earnings Per Common Share to As Reconciled Amounts for Net Income

Available to Common Shareholders and Diluted Earnings per Common Share

(Amounts in Millions, except per share figures)

Nine months ended September 30, 2008

(unaudited)

-------------------------------------------------------

Special and

Purchase Acquisition- Other As

As Accounting Related Specified Reconciled

Reported Adjustments Items Items (1)

-------------------------------------------------------

Net sales $14,154 $- $- $- $14,154

Cost of sales 5,782 (1,
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine news :

1. Schering-Plough Announces Transition of Animal Health Leadership
2. Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
3. Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
4. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
5. Bayer/Schering-Plough/Shionogis Avelox Has Advantages Over Levofloxacin in the Treatment of Community-Acquired Pneumonia
6. Schering-Plough Announces Expanded Stock Retention Guidelines for Senior Management
7. Schering-Plough to Webcast Presentation by CEO Fred Hassan at Lehman Brothers Eleventh Annual Global Healthcare Conference
8. Schering-Plough Promotes Ian Mcinnes to President of Global Supply Chain
9. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
10. Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough
11. Schering-Plough CEO to Buy $2 Million in Common Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... If there is one thing that drives parents into a ... at their child’s school. While head lice are not particularly ... of a nightmare for many parents as they see the ... their child’s classroom. Just when they think the problem is ... Local lice removal company, Lice Troopers , reports that ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Qualis ... management organizations, has been named a finalist in ... in recognition of outstanding commitment toward continuous improvement ... success in reducing hospital readmission rates through its ... “We are honored to receive this national recognition, ...
(Date:2/27/2015)... A fireplace can cause the average home to ... the chimney’s flue when the fireplace is not in use. ... solved with the introduction of a new small fireplace DraftStopper. ... 18" in diameter when inflated. It is quickly and easily ... damper. This size unit fits into round dampers, which are ...
(Date:2/27/2015)... The Connecticut Community for Addiction Recovery (CCAR) recently ... Drug Recovery Centers (ADRC), for its shared Recovery Oriented ... with the 2014 Commissioner’s Recognition Award by the CT ... Last year, ROES achieved the highest rate of employment ... from alcoholism and other drug addiction. More than ...
(Date:2/27/2015)... 27, 2015 Lewis Clinic Dentistry has extended ... 4PM to make its services available for patients who cannot ... from the Lewis Clinic Dentistry said, “Yes, we have extended ... on weekdays due to their busy schedules and work can ... to make more people’s lives beautiful and smiling.” He further ...
Breaking Medicine News(10 mins):Health News:Anxiety over head lice among Miami parents as surge in head lice cases reported by local lice removal company Lice Troopers 2Health News:Qualis Health Named Award Finalist for Care Transitions Work 2Health News:New DraftStopper from Tamarack Technologies Stops Heat Loss When Fireplace Not in Use 2Health News:Lewis Clinic Dentistry Extends Business Hours 2
... Aug. 22 , What: The American Academy of Actuaries, Public Interest Committee ... hear views on the disclosure of ... plans. The committee will use information obtained through ... board of directors on the issue is appropriately in the ...
... (Nasdaq: NXTM ), a leading manufacturer of ... of life analysis from,the FREEDOM study will be ... 2008 Annual Meeting taking place November 4-9, 2008,in ... (DHD),Improves Quality of Life (QoL) Measures, Depressive Symptoms ...
... Medicare Part B transaction ... its stores nationwide, FORT WORTH, Texas, Aug. 22 ... the retail pharmacy,industry, announced today that it will provide transaction ... state,Medicaid DME claims and clinical administration programs to Rite Aid. ...
... Group (CAHG),is proud to announce the promotion of ... eInnovation, Corbett Accel Healthcare,Group (CAHG). In his new ... Executive,Leadership Team of CAHG, and continue as Managing ... Melick is based in,CAHG,s Chicago office and will ...
... RESTON, Va.SNM and the American Society for Therapeutic ... this fall examining the impact of translational advances ... meeting, which takes place October 17-18, will bring ... young investigators in the emerging field of molecular ...
... CMS, Inc., an Elekta Company, and,worldwide leader ... received FDA 510(k) clearance for its new Atlas-Based,Autosegmentation ... distributing Atlas-Based Autosegmentation for clinical use in the,United ... spent creating and editing,patient contours, ABAS is a ...
Cached Medicine News:Health News:Actuaries to Host Forum on Public Pension Disclosures 2Health News:Actuaries to Host Forum on Public Pension Disclosures 3Health News:NxStage Announces Presentation of Data at the American Society of Nephrology's Renal Week 2008 Annual Meeting 2Health News:eRx Network to Provide Transaction Processing and Revenue Cycle Management Services to Rite Aid 2Health News:Corbett Accel Healthcare Group Announces Promotion of Geoff Melick to Executive Vice President, Interactive Marketing & eInnovation 2Health News:SNM and ASTRO team up to advance molecular imaging and cancer research 2Health News:CMS, Inc., an Elekta Company, Receives FDA 510(k) Clearance for Atlas-Based Autosegmentation Software 2
(Date:2/26/2015)... YORK , Feb. 26, 2015 ... Latin America is estimated at 2.4 ... said that population growth, government insurance, newly insured ... in the region and will continue to propel ... on torresearch into the market and interviews with ...
(Date:2/26/2015)... BOSTON , Feb. 26, 2015 ... ("Columbia" or "the Company"), a specialty pharmaceutical company ... health, plans to initiate a Phase II clinical ... in women undergoing transvaginal pipelle-directed endometrial biopsy in ... pre-Investigational New Drug ("IND") submission feedback from the ...
(Date:2/26/2015)... Feb. 26, 2015  Technological advancements have ... effective, inexpensive and compact yet powerful solutions. ... small-scale, potent devices, lending momentum to the ... http://photos.prnewswire.com/prnh/20150225/177944LOGO New ... Nanomanufacturing, finds that nanomanufacturing will gain traction ...
Breaking Medicine Technology:Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 2Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 3Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 4Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 2Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 3Revolutionary Nanomanufacturing Technology to Approach Commercialization by 2020 2Revolutionary Nanomanufacturing Technology to Approach Commercialization by 2020 3Revolutionary Nanomanufacturing Technology to Approach Commercialization by 2020 4
... II Study Demonstrates Significant,Additional Improvement for Patients ... /PRNewswire-FirstCall/ --,Indevus Pharmaceuticals, Inc. today announced that ... for pagoclone in persistent,developmental stuttering will be ... the New Clinical Drug Evaluation Unit (NCDEU), ...
... Insomnia on Healthcare System and,Worker Productivity, SAN ... Inc. announced today that results from several,research ... and transient,insomnia were presented this week at ... APSS highlights show that,insomnia is significantly under-diagnosed ...
Cached Medicine Technology:Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 2Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 3Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 4Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 5Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 7Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 8Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 9Neurocrine Biosciences Announces New Research Studies Presented at,APSS Reveal Significant Under-Diagnosis of Insomnia 2Neurocrine Biosciences Announces New Research Studies Presented at,APSS Reveal Significant Under-Diagnosis of Insomnia 3Neurocrine Biosciences Announces New Research Studies Presented at,APSS Reveal Significant Under-Diagnosis of Insomnia 4Neurocrine Biosciences Announces New Research Studies Presented at,APSS Reveal Significant Under-Diagnosis of Insomnia 5
... difficile Panel is an enzyme immunoassay used ... antigen (glutamate dehydrogenase) and toxin A in ... as an aid in the diagnosis of ... of the Triage Microbiology product line, designed ...
ELISA for the detection of C. difficile toxin A in stool specimens...
... CCD cameras provide fast, accurate, reliable and ... quality at an excellent price. , , ... TOMEY TR-4000 Auto Refractor provides highly accurate ... is obtained simply by pushing a button. ...
... SP-3000 covers all needs regarding pachymetry in ... care., ,Compact design, colored touch-screen and "quick ... an "easy-to-use unit.,The wide measurement range from ... the possibility to measure very thin or ...
Medicine Products: